Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Steve Harr > Profile

Steve Harr

Affiliations

  • President & Ceo at Sana Biotechnology Inc. (SANA), 2025-03-11
  • Director at Loxo Oncology Inc. (LOXO), 2019-02-15
  • Cfo & Head, Corp. Development at Juno Therapeutics Inc. (JUNO), 2018-03-07
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
JUNO $45.18 500 $22,591.00 763,332 2017-12-21 Filing
JUNO $44.74 8,250 $369,082.73 763,832 2017-12-21 Filing
JUNO $30.00 8,750 $262,500.00 727,439 2017-07-03 Filing
JUNO $30.00 8,750 $262,500.88 727,439 2017-06-27 Filing
JUNO $43.69 16,052 $701,369.67 700,000 2016-06-10 Filing